The global Wireless Medical Technologies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending co...
Bionics also known as biomedical implants are artificial addition to the body. These artificial implants mimic the function of the lost or non-functional body part such as limb or eye.
The global Medical Bionics market was valued at US$ 16430 million in 2023 and is anticipated to reach US$ 25010 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
According to our res...
Medical imaging services involves imagining of the body parts, tissues, and organs used for diagnosis, monitoring, and treatment of diseases. Mobile medical imaging services provides technologies such as MRI, PET/CT, Ultrasound, X-Ray, ECG, Holter monitoring, and other services on mobile platforms.
The global Medical Imaging Services market was valued at US$ million in 2023 and is anticipated to...
Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.
The global Acute Intermittent Porphyria Treatment market was valued at US$ 49 million in 2023...
Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.
The global Acute Intermittent Porphyria Therapeutics market was valued at US$ 49 million in 20...
Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.
The global Swedish Porphyria Treatment market was valued at US$ 49 million in 2023 and is anticipated to reach US$ 56 million by 2030, witnessing a CAGR of 1.8% during the forecast period 202...
Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.
The global Swedish Porphyria Therapeutics market was valued at US$ 49 million in 2023 and is anticipated to reach US$ 56 million by 2030, witnessing a CAGR of 1.8% during the forecast period...
Wound care devices and products are used to prevent infection and promote healing of the wound.
The global Medical Devices Technologies Woundcare market was valued at US$ 20700 million in 2023 and is anticipated to reach US$ 29520 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
Factors such as increasing prevalence of chronic wounds, rising geriatric population,...
Antibiotic drugs are the basis of urinary tract infection treatment. Antibiotic treatment involves determining the type of bacteria present and choosing the appropriate drug. Antibacterials for urine infections include nalidixic acid, nitrofurantoin, ofloxacin and norfloxacin (for complicated urinary tract infections).
The global Treatment for Genito-Urinary market was valued at US$ 28510 million...
In this report, we study the drugs for Hematology. Hematology is the science or study of blood, blood-forming organs and blood diseases. In the medical field, hematology includes the treatment of blood disorders and malignancies, including types of hemophilia, leukemia, lymphoma and sickle-cell anemia.
The global Hematology Treatment market was valued at US$ 33610 million in 2023 and is anticipat...
Our team would be happy to assist you with your queries.
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals